title: Analysis of CD95 and CCR7 expression on circulating CD4(+) lymphocytes revealed disparate immunoregulatory potentials in systemic lupus erythematosus.
abstract: Emerging data have implicated a critical role for CD4 in the pathogenesis of systemic lupus erythematosus (SLE). This study was designed to delineate the contribution of CD4(+) T cells in the pathogenesis of SLE disease. Forty-four patients (3 male: 41 female) and 20 healthy volunteers (4 male: 16 female) were included in the study. CD4(+) lymphocytes analysis was done using three-color flow cytometry with antibodies against human-CD95, a prototype cell death receptor, and the chemokine receptor-7 (CCR7) after gating for lymphocytes based on the forward and side scatter. Serum levels of IL-6, IL-12, IL-17, TNF-α and IL-10 cytokines were assayed using ELISA. Disease activity was assessed using the SLE disease activity index (SLEDAI). Based on the expression of CCR7 and CD95, CD4(+) lymphocytes were subdivided into three particular subsets; CD4(+)CD95(+)CCR7(+) cells, CD4(+)CD95(-)CCR7(+) cells and CD4(+)CD95(+)CCR7(-) cells. Percentage of CD4(+)CD95(+)CCR7(+) cell subset was significantly higher in patients with SLE with active disease (SLEDAI > 6) and inactive (SLEDAI < 6) as compared with controls (P = 0.005), and it showed a significant positive correlation with ANA titer (P = 0.01), and a negative correlation with WBCs count (P = 0.001). CD4(+)CD95(+)CCR7(-) cell subset was significantly higher in active SLE patients in comparison to patients with inactive disease and controls (P = 0.05, P = 0.005 respectively), and it correlates positively with SLEDAI, IL-6 and IL-17 levels (P = 0.001, 0.05, 0.01 respectively), and negatively with blood WBCs counts (P = 0.001). The third CD4(+)CD95(-)CCR7(+)cell subset was found significantly lower in SLE patients compared with controls, and it was found negatively correlated with IL-10, IL-6, and IL-17. The results show that CD4(+)CD95(+)subset lacking expression of CCR7 is associated with cell mediated inflammatory response as manifested by its correlation with signs of inflammation, inflammatory cytokines and disease activity index. Whereas, CD4(+)CD95(+)CCR7(+) correlate more with antibody immune responses as manifested by association with serum ANA. These data suggest disparate roles of these cell subsets in the pathophysiology of SLE. A better understanding of the characteristics of CD4 cell subsets may shed light on the pathogenesis of autoimmune diseases, particularly SLE.
authors: Biological Sciences Department, King Abdulaziz University, Jeddah, Saudi Arabia; Immunology Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
authors: Alia M
authors: AM
authors: Aldahlawi
authors: Biochemistry Department - Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia; Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, Sadat City University, Egypt.
authors: Mohamed F
authors: MF
authors: Elshal
authors: Biological Sciences Department, King Abdulaziz University, Jeddah, Saudi Arabia.
authors: Laila A
authors: LA
authors: Damiaiti
authors: Laboratory Technology Department - Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
authors: Laila H
authors: LH
authors: Damanhori
authors: Rheumatology Unit, Internal Medicines Department - Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
authors: Sami M
authors: SM
authors: Bahlas
keywords: Apoptosis; CCR7; CD95; Chemokine receptor; Disease activity; Flow cytometry; Systemic lupus erythematosus